| scholarly article | Q13442814 |
| P50 | author | Stefanie Dimmeler | Q110856 |
| Birgit Assmus | Q86379036 | ||
| Alexandra Aicher | Q86950497 | ||
| Winfried Brenner | Q89882342 | ||
| Cornel Badorff | Q117267669 | ||
| Thomas Eckey | Q117267698 | ||
| Schirin Massoudi | Q117267699 | ||
| Maaz Zuhayra | Q117267700 | ||
| Eberhard Henze | Q117267701 | ||
| Andreas Zeiher | Q501318 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 2134-2139 | |
| P577 | publication date | 2003-04-14 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling | |
| P478 | volume | 107 |
| Q48794013 | (18)F-FDG cell labeling may underestimate transplanted cell homing: more accurate, efficient, and stable cell labeling with hexadecyl-4-[(18)F]fluorobenzoate for in vivo tracking of transplanted human progenitor cells by positron emission tomography |
| Q33570359 | A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype |
| Q82341147 | A novel mechanism for endothelial progenitor cells homing: The SDF-1/CXCR4–Rac pathway may regulate endothelial progenitor cells homing through cellular polarization |
| Q39879067 | AAV-2-mediated expression of IGF-1 in skeletal myoblasts stimulates angiogenesis and cell survival |
| Q30492675 | Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells |
| Q54622134 | Adrenomedullin augments the angiogenic potential of late outgrowth endothelial progenitor cells. |
| Q36815983 | Adult stem cells and heart regeneration |
| Q48548226 | Alginate microencapsulation of human mesenchymal stem cells as a strategy to enhance paracrine-mediated vascular recovery after hindlimb ischaemia. |
| Q53180617 | An emerging cell-based strategy in orthopaedics: endothelial progenitor cells. |
| Q28567725 | Angiogenic effect of endothelial progenitor cells transfected with telomerase reverse transcriptase on peritubular microvessel in five out of six subtotal nephrectomy rats |
| Q33680007 | Assessment and optimization of cell engraftment after transplantation into the heart |
| Q50279365 | Augmented neovascularization with magnetized endothelial progenitor cells in rats with hind-limb ischemia |
| Q48909705 | Autologous endothelial progenitor cells transplantation promoting endothelial recovery in mice |
| Q42593149 | Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety |
| Q45876829 | Autologous vascular smooth muscle cell-based myocardial gene therapy to induce coronary collateral growth |
| Q36797965 | Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia |
| Q37178066 | Bioengineering to enhance progenitor cell therapeutics |
| Q34821264 | Biological effects of anti-CD34-coated ePTFE vascular grafts. Early in vivo experimental results |
| Q42639187 | Biological surgery: synergetic angiogenic therapy using coadministration of two progenitor cell populations |
| Q36127860 | Biomaterial strategies to improve the efficacy of bone marrow cell therapy for myocardial infarction |
| Q37637396 | Bone marrow cell therapies for endothelial repair and their relevance to kidney disease |
| Q27006710 | Bone marrow mononuclear cells and acute myocardial infarction |
| Q35147795 | Bridging the gap: a Canadian perspective on translational kidney research |
| Q43207208 | Canine adipose-derived stromal cell viability following exposure to synovial fluid from osteoarthritic joints |
| Q37371934 | Cardiac cell repair therapy: a clinical perspective |
| Q35144550 | Cardiac cell therapy: where we've been, where we are, and where we should be headed |
| Q36406439 | Cardiac cell-repair therapy: clinical issues |
| Q26822619 | Cardiac regeneration therapy: connections to cardiac physiology |
| Q37253735 | Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease |
| Q36579504 | Cardiac repair--fact or fancy? |
| Q38014708 | Cell delivery routes for stem cell therapy to the heart: current and future approaches. |
| Q27347330 | Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold |
| Q38226693 | Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences. |
| Q35589728 | Cell tracking in cardiac repair: what to image and how to image. |
| Q35547250 | Cell transplantation and genetic engineering: new approaches to cardiac pathology |
| Q36277263 | Cell-based therapies and imaging in cardiology |
| Q37096959 | Cellular MRI and its role in stem cell therapy |
| Q35847332 | Cellular approaches to tissue repair in cardiovascular disease: the more we know, the more there is to learn |
| Q37638266 | Cellular cardiomyoplasty and cardiac regeneration |
| Q39410733 | Cellular mechanisms underlying cardiac engraftment of stem cells. |
| Q38086843 | Choice of cell-delivery route for successful cell transplantation therapy for the heart |
| Q33734834 | Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart |
| Q40171747 | Comparison of imaging techniques for tracking cardiac stem cell therapy |
| Q36406455 | Contemplating the bright future of stem cell therapy for cardiovascular disease |
| Q37731746 | Current perspectives on imaging cardiac stem cell therapy |
| Q37455469 | Development of bioactive peptide amphiphiles for therapeutic cell delivery |
| Q45072634 | Diabetic Microvascular Disease: An Endocrine Society Scientific Statement |
| Q34768493 | Differential biodistribution of intravenously administered endothelial progenitor and cytotoxic T-cells in rat bearing orthotopic human glioma. |
| Q34956358 | Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction |
| Q30477220 | Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction |
| Q42292968 | Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis |
| Q39392818 | Effect of hypoxia on integrin-mediated adhesion of endothelial progenitor cells. |
| Q36762963 | Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. |
| Q36922455 | Emerging role of circulating calcifying cells in the bone-vascular axis |
| Q35944159 | Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective |
| Q47141294 | Endothelial Progenitor Cells for Ischemic Stroke: Update on Basic Research and Application |
| Q43199692 | Endothelial progenitor cell function, apoptosis, and telomere length in overweight/obese humans |
| Q37992761 | Endothelial progenitor cells and integrins: adhesive needs |
| Q53859573 | Endothelial progenitor cells delivered into the pericardial space incorporate into areas of ischemic myocardium |
| Q37176444 | Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies. |
| Q33705402 | Endothelial progenitor cells: therapeutic perspective for ischemic stroke |
| Q88331120 | Endothelial vascular markers in coronary surgery |
| Q34055868 | Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix |
| Q96109649 | Evidence of Accumulated Endothelial Progenitor Cells in the Lungs of Rats with Pulmonary Arterial Hypertension by 89Zr-oxine PET Imaging |
| Q53544638 | Feasibility of in vivo dual-energy myocardial SPECT for monitoring the distribution of transplanted cells in relation to the infarction site. |
| Q36569726 | From cardiac repair to cardiac regeneration--ready to translate? |
| Q26865425 | Gene and cell therapies for the failing heart to prevent sudden arrhythmic death |
| Q36675432 | Gene and cell therapy for chronic ischaemic heart disease |
| Q37096297 | Homing and engraftment of progenitor cells: a prerequisite for cell therapy |
| Q45863035 | Human blood late outgrowth endothelial cells for gene therapy of cancer: determinants of efficacy |
| Q37871466 | Imaging cardiac stem cell therapy: translations to human clinical studies |
| Q34340761 | Imaging of cells and nanoparticles: implications for drug delivery to the brain |
| Q37163866 | Imaging stem cell implant for cellular-based therapies |
| Q36656791 | Imaging stem cells implanted in infarcted myocardium |
| Q58596804 | Impaired adhesion of induced pluripotent stem cell-derived cardiac progenitor cells (iPSC-CPCs) to isolated extracellular matrix from failing hearts |
| Q57188059 | Improved route for the visualization of stem cells labeled with a Gd-/Eu-chelate as dual (MRI and fluorescence) agent |
| Q42920942 | In Vivo Differentiation of Magnetically Labeled Mesenchymal Stem Cells Into Hepatocytes for Cell Therapy to Repair Damaged Liver |
| Q26765900 | In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine |
| Q37853947 | In vivo biodistribution of stem cells using molecular nuclear medicine imaging |
| Q37440349 | In vivo imaging of stem cells and Beta cells using direct cell labeling and reporter gene methods |
| Q34049277 | In vivo tracking of transplanted mononuclear cells using manganese-enhanced magnetic resonance imaging (MEMRI) |
| Q61612309 | Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells |
| Q49108639 | Inhibition of microRNA-495 Enhances Therapeutic Angiogenesis of Human Induced Pluripotent Stem Cells |
| Q53362103 | Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges. |
| Q27025843 | Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction? |
| Q46515972 | Intracoronary delivery of bone marrow cells to the acutely infarcted myocardium. Optimization of the delivery technique. |
| Q52800695 | Is There a Role for Intravenous Stem Cell Delivery in Nonischemic Cardiomyopathy? |
| Q48932406 | Labelling of human mesenchymal stem cells with indium-111 for SPECT imaging: effect on cell proliferation and differentiation |
| Q36931684 | Long term non-invasive imaging of embryonic stem cells using reporter genes |
| Q33564003 | Long-term tracking of bone marrow progenitor cells following intracoronary injection post-myocardial infarction in swine using MRI. |
| Q24646424 | Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization |
| Q36746521 | MR imaging in assessing cardiovascular interventions and myocardial injury |
| Q35963080 | MRI/SPECT/Fluorescent Tri-Modal Probe for Evaluating the Homing and Therapeutic Efficacy of Transplanted Mesenchymal Stem Cells in a Rat Ischemic Stroke Model |
| Q50042694 | Magnetic Resonance and Photoacoustic Imaging of Brain Tumor Mediated by Mesenchymal Stem Cell-Labeled with Multifunctional Nanoparticle Introduced via Carotid Artery Injection |
| Q36804563 | Magnetic resonance imaging and its role in myocardial regenerative therapy |
| Q51201458 | Magnetic targeting of human mesenchymal stem cells with internalized superparamagnetic iron oxide nanoparticles. |
| Q38912392 | Maintenance of HL-1 cardiomyocyte functional activity in PEGylated fibrin gels |
| Q38124756 | Mechanistic molecular imaging of cardiac cell therapy for ischemic heart disease |
| Q90683736 | Mending a broken heart: current strategies and limitations of cell-based therapy |
| Q35040934 | Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture |
| Q35099504 | Mesenchymal stem cells ameliorate Th1-induced pre-eclampsia-like symptoms in mice via the suppression of TNF-α expression |
| Q38625663 | Mesenchymal stem cells and chronic renal artery stenosis |
| Q64921890 | Metabolism of Stem and Progenitor Cells: Proper Methods to Answer Specific Questions. |
| Q34807143 | Methods to assess stem cell lineage, fate and function |
| Q34241026 | MicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGF |
| Q37199481 | Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair |
| Q34805586 | Modulating the Adhesion of Haematopoietic Stem Cells with Chemokines to Enhance Their Recruitment to the Ischaemically Injured Murine Kidney |
| Q30477168 | Molecular Imaging of Stem Cell Transplantation in Myocardial Disease |
| Q36700579 | Molecular cardiovascular imaging using scintigraphic methods |
| Q37600765 | Molecular imaging in clinical trials |
| Q36853933 | Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium |
| Q35856369 | Molecular imaging of cardiovascular gene products |
| Q30489494 | Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles |
| Q57340655 | Multifunctional Upconversion Nanoparticles for Dual-Modal Imaging-Guided Stem Cell Therapy under Remote Magnetic Control |
| Q38045804 | Myocardial regeneration of the failing heart |
| Q35778889 | Myocardial restoration: is it the cell or the architecture or both? |
| Q36304191 | Myocardial-cell replacement: the science, the clinic and the future |
| Q33864915 | Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia. |
| Q38454484 | Non-cultured dermal-derived mesenchymal cells attenuate sepsis induced by cecal ligation and puncture in mice. |
| Q90267302 | Non-inferiority of microencapsulated mesenchymal stem cells to free cells in cardiac repair after myocardial infarction: A rationale for using paracrine factor(s) instead of cells |
| Q38129057 | Non-invasive in-vivo imaging of stem cells after transplantation in cardiovascular tissue |
| Q37767614 | Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium. |
| Q36136721 | Noninvasive imaging of cardiac gene expression and its future implications for molecular therapy |
| Q33576955 | Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery |
| Q37907966 | Noninvasive stem cell tracking |
| Q35203798 | Norepinephrine stimulates mobilization of endothelial progenitor cells after limb ischemia |
| Q36666478 | Nuclear imaging in cardiac cell therapy |
| Q41389712 | One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction |
| Q38353261 | Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke. |
| Q35785713 | PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells |
| Q27304850 | Paracrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine hearts |
| Q29620571 | Paracrine mechanisms in adult stem cell signaling and therapy |
| Q36742274 | Pathophysiology of tumor neovascularization |
| Q51529070 | Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue. |
| Q41240124 | Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury |
| Q53236739 | Positron emission tomography for the evaluation and treatment of cardiomyopathy. |
| Q47093712 | Preclinical Evaluation and Optimization of a Cell Therapy Using Human Cord Blood-Derived Endothelial Colony-Forming Cells for Ischemic Retinopathies |
| Q35821434 | Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. |
| Q40457855 | Progenitor cell therapy of ischemic heart disease: the new frontier. |
| Q36327823 | Progress and prospects: cell based regenerative therapy for cardiovascular disease. |
| Q30382050 | Protein microarray biosensors based on imaging ellipsometry techniques and their applications. |
| Q37606452 | Pulp cell tracking by radionuclide imaging for dental tissue engineering. |
| Q35153280 | R2* and R2 mapping for quantifying recruitment of superparamagnetic iron oxide-tagged endothelial progenitor cells to injured liver: tracking in vitro and in vivo |
| Q35930750 | RNA-Seq Reveals the Angiogenesis Diversity between the Fetal and Adults Bone Mesenchyme Stem Cell |
| Q35459718 | Rafs constitute a nodal point in the regulation of embryonic endothelial progenitor cell growth and differentiation |
| Q34544884 | Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity |
| Q51483976 | Renovascular hypertension: Effects of mesenchymal stem cells in the contralateral hypertensive kidney in rats. |
| Q41494185 | Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy |
| Q42633454 | Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction |
| Q36402579 | Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells |
| Q37964251 | Role of molecular imaging in stem cell therapy for myocardial restoration |
| Q37975993 | SPECT and PET to optimize cardiac stem cell therapy |
| Q46187842 | Scintigraphic evaluation of intra-arterial and intravenous regional limb perfusion of allogeneic bone marrow-derived mesenchymal stem cells in the normal equine distal limb using (99m) Tc-HMPAO. |
| Q41591175 | Scintigraphic tracking of mesenchymal stem cells after portal, systemic intravenous and splenic administration in healthy beagle dogs |
| Q48566449 | Second Annual Mario S. Verani, MD, Memorial Lecture: Nuclear cardiology, the next 10 years |
| Q43239856 | Serial in vivo imaging of the porcine heart after percutaneous, intramyocardially injected 111In-labeled human mesenchymal stromal cells |
| Q30638284 | Single-cell tracking with PET using a novel trajectory reconstruction algorithm |
| Q38735552 | Specific recruitment of circulating angiogenic cells using biomaterials as filters |
| Q48774892 | State-of-the-Art in Tissue-Engineered Heart Repair |
| Q39043962 | Stem Cell Monitoring with a Direct or Indirect Labeling Method |
| Q38637333 | Stem Cell Smart Technology, where are we now and how far we have to go? |
| Q39124190 | Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise |
| Q37790972 | Stem Cells and Burns: Review and Therapeutic Implications |
| Q85240790 | Stem and progenitor cell-based therapy approaches: current developments on treatment of acute myocardial infarction and chronic ischemic cardiomyopathy |
| Q34981433 | Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges |
| Q34988926 | Stem cell labeling for noninvasive delivery and tracking in cardiovascular regenerative therapy |
| Q38209423 | Stem cell therapies in the management of diabetic retinopathy |
| Q38603660 | Stem cell therapies in the treatment of diabetic retinopathy and keratopathy |
| Q36836349 | Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology |
| Q38761212 | Stem cell therapy for ischemic heart diseases |
| Q33348580 | Stem cell therapy: pieces of the puzzle |
| Q36368239 | Stem cell transplantation for the treatment of myocardial infarction |
| Q35128063 | Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation |
| Q53413645 | Stem cell: "KANT" you see it? |
| Q36842866 | Stem cells and cardiac regeneration |
| Q57635832 | Stem cells and cardiovascular tissue repair: Mechanism, methods, and clinical applications |
| Q35910261 | Stem cells and muscle diseases. |
| Q37708148 | Stem cells for heart failure in the aging heart |
| Q36446920 | Stem cells for the ischaemic heart |
| Q90054552 | Supercritical Carbon Dioxide-decellularized Porcine Acellular Dermal Matrix combined with Autologous Adipose-derived Stem Cells: Its Role in Accelerated Diabetic Wound Healing |
| Q33304571 | Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats |
| Q44994608 | Targeted delivery of adipose-derived stem cells via acellular dermal matrix enhances wound repair in diabetic rats |
| Q36822315 | The role of endothelial progenitor cells in ischemic cerebral and heart diseases |
| Q48938444 | The role of noninvasive imaging techniques in the assessment of stem cell therapy after acute myocardial infarction |
| Q54425427 | The spleen recruits endothelial progenitor cell via SDF-1/CXCR4 axis in mice. |
| Q37053163 | The therapeutic potential of stem cells in heart disease |
| Q35949643 | Therapeutic myocardial angiogenesis: past, present and future |
| Q101451663 | Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders |
| Q38035076 | Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells |
| Q40953471 | Three-dimensional spatiotemporal tracking of fluorine-18 radiolabeled yeast cells via positron emission particle tracking |
| Q46929683 | Thrombin and PAR-1 stimulate differentiation of bone marrow-derived endothelial progenitor cells |
| Q92677843 | Tissue Engineering of the Microvasculature |
| Q42575579 | Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses |
| Q35691795 | Tracking stem cells for cardiovascular applications in vivo: focus on imaging techniques |
| Q37479807 | Tracking the migration of cardially delivered therapeutic stem cells in vivo: state of the art. |
| Q51549947 | Transplantation of Marrow-Derived Cardiac Stem Cells Carried in Fibrin Improves Cardiac Function After Myocardial Infarction |
| Q35941293 | Transplantation of bradykinin-preconditioned human endothelial progenitor cells improves cardiac function via enhanced Akt/eNOS phosphorylation and angiogenesis |
| Q54853045 | Transplantation of bradykinin-preconditioned human endothelial progenitor cells improves cardiac function via enhanced Akt/eNOS phosphorylation and angiogenesis. |
| Q48175406 | Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke |
| Q34694874 | Treatment with a vascular disrupting agent does not increase recruitment of indium labelled human endothelial outgrowth cells in an experimental tumour model |
| Q33683767 | Unchain my heart: the scientific foundations of cardiac repair |
| Q37194131 | Understanding the application of stem cell therapy in cardiovascular diseases |
| Q45608600 | Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors. |
| Q34994515 | Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle |
| Q39174289 | Vascular precursor cells in tissue injury repair |
| Q37115995 | Vascular progenitor cells and diabetes: role in postischemic neovascularisation. |
| Q79449730 | [Cell tracking. Principles and applications] |
| Q80214401 | [Regenerative therapy in cardiology: how distant is it from reality?] |
| Q54242794 | cxcl12 gene engineered endothelial progenitor cells further improve the functions of oligodendrocyte precursor cells. |
Search more.